A detailed history of Quent Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Quent Capital, LLC holds 4,943 shares of LLY stock, worth $4.48 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
4,943
Previous 4,943 -0.0%
Holding current value
$4.48 Million
Previous $3.85 Million -0.0%
% of portfolio
0.46%
Previous 0.46%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $147,457 - $197,277
249 Added 5.3%
4,943 $3.85 Million
Q4 2023

Jun 14, 2024

BUY
$525.19 - $619.13 $181,190 - $213,599
345 Added 7.93%
4,694 $2.74 Million
Q4 2023

Jan 19, 2024

BUY
$525.19 - $619.13 $181,190 - $213,599
345 Added 7.93%
4,694 $2.74 Million
Q3 2023

Jun 14, 2024

SELL
$434.7 - $599.3 $32,167 - $44,348
-74 Reduced 1.67%
4,349 $2.34 Million
Q3 2023

Oct 10, 2023

SELL
$434.7 - $599.3 $32,167 - $44,348
-74 Reduced 1.67%
4,349 $2.34 Million
Q2 2023

Jun 14, 2024

BUY
$350.74 - $468.98 $16,835 - $22,511
48 Added 1.1%
4,423 $2.07 Million
Q2 2023

Jul 10, 2023

BUY
$350.74 - $468.98 $16,835 - $22,511
48 Added 1.1%
4,423 $2.07 Million
Q1 2023

Jun 14, 2024

SELL
$310.63 - $364.82 $176,437 - $207,217
-568 Reduced 11.49%
4,375 $1.5 Million
Q1 2023

Apr 05, 2023

BUY
$310.63 - $364.82 $53,117 - $62,384
171 Added 4.07%
4,375 $1.5 Million
Q4 2022

Jan 19, 2023

BUY
$321.55 - $374.67 $98,072 - $114,274
305 Added 7.82%
4,204 $0
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $56,924 - $64,871
192 Added 5.18%
3,899 $1.26 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $567,215 - $665,994
-2,035 Reduced 35.44%
3,707 $1.2 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $283,036 - $351,741
-1,206 Reduced 17.36%
5,742 $1.64 Million
Q4 2021

May 12, 2022

BUY
$224.85 - $279.04 $539,640 - $669,696
2,400 Added 52.77%
6,948 $1.92 Million
Q4 2021

Feb 28, 2022

BUY
$224.85 - $279.04 $1.02 Million - $1.27 Million
4,548 New
4,548 $1.26 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.